News BioRegenx, Inc.

Equities

BRGX

US31772N1000

Market Closed - OTC Markets Other stock markets 11:34:15 2024-07-11 am EDT			5-day change	1st Jan Change
0.025 ^USD	-9.58%		-37.50%	+6.38%

Mar. 08	BioRegenx, Inc. completed the acquisition of Findit, Inc. from WooEB, Inc., Hva Family Trust and others in a reverse merger transaction.	CI
2023	Findit, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

BioRegenx : Non Reliance on Previously Issued Financial Report Form 8 K	Jun. 11	PU
FINDIT : Management Change/Compensation - Form 8-K	Apr. 01	PU
BioRegenx, Inc. completed the acquisition of Findit, Inc. from WooEB, Inc., Hva Family Trust and others in a reverse merger transaction.	Mar. 07	CI
Findit, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20	CI
Findit, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-15	CI
Findit, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22	CI
Findit, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-04	CI
FINDIT, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-04-04	AQ
Findit, Inc. Auditor Raises 'Going Concern' Doubt	23-04-03	CI
FINDIT, INC. : Entry into a Material Definitive Agreement (form 8-K)	23-01-06	AQ
BioRegenx, Inc. entered into a Definitive Agreement to acquire Findit, Inc. in a reverse merger transaction.	22-12-28	CI
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-21	AQ
Findit, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-21	CI
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-12	AQ
Findit, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12	CI
Findit : Announces Investor Update	22-07-29	PU
Findit : Featured Member BioRegenx Announces Investor Update	22-07-19	PU
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-05-23	AQ
Findit, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-23	CI
FINDIT, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	22-04-13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News BioRegenx, Inc.

Equities

BRGX

US31772N1000

Summary

Filters